AMC Robotics Corporation is an AI-driven robotics company focused on intelligent, scalable hardware and software solutions. Its flagship quadruped platform, Kyro, is designed to automate inspection, security, and operational tasks through autonomous mobility and AI-powered perception, while NovaArm targets warehouse logistics automation. The company also markets a portfolio of AI-enabled YI security cameras sold through e-commerce channels across the United States, Canada, and Europe.
The company began trading on the Nasdaq Capital Market under the ticker AMCI in December 2025 after completing a business combination with AlphaVest Acquisition Corp, a special purpose acquisition company. For fiscal 2025, AMC Robotics reported revenue of approximately $6.0 million and a gross margin near 48%, alongside a GAAP net loss of roughly $24.8 million driven largely by a non-cash warrant fair-value adjustment. Investors follow the stock for its exposure to the fast-growing AI robotics and warehouse-automation themes, though its early-stage revenue base and financing needs make it a higher-risk, high-volatility name. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the past 30 days, AMC Robotics shares declined approximately 37.7%, falling from a closing price of $3.32 on September 30 to around $2.07 on the latest available data. The slide was steady rather than a single-event collapse, with the stock posting repeated lower closes through October and touching the low-$2 range in the final week of the period.
The move extends a longer downtrend. Over the trailing quarter, the stock has shed roughly 60%, declining from about $5 in late July to the low-$2 area. After spiking toward the mid-$6 level in August, shares entered a sustained downtrend as financing and dilution concerns took precedence over product-related announcements. The combination of a sharp 30-day drop and an extended quarterly decline places the stock near the lower end of its 52-week range.
The dominant driver of the 30-day decline was dilution risk. AMC Robotics entered a standby equity purchase agreement providing up to $50 million in potential funding, and because the share issuance involved could exceed Nasdaq's 19.99% limit, the company scheduled a shareholder vote for December 2026. Market participants have reacted negatively to the prospect of significant additional share issuance at a depressed price, contributing to persistent selling pressure.
Financing-related activity compounded the concern, including a warrant inducement transaction for up to $2.1 million in gross proceeds and updates on the company's Vietnam manufacturing buildout targeting roughly $30 million in annual production capacity. While the company also announced the appointment of AI and machine-learning expert Dr. Ang Li as Chief Technology Officer and a strategic investment in Etronium AI, these developments were insufficient to offset dilution fears and broader execution uncertainty around the Kyro and NovaArm product launches.
The quarterly decline reflects a broader reassessment of the company's financing path and its distance from meaningful commercialization. After an August rally that briefly pushed shares above $6, the stock reversed sharply as investors weighed the company's thin cash position, reported near $4.5 million as of mid-2026, against the capital required to scale manufacturing and launch its robotics products.
A delayed annual report filing earlier in the year, tied to the accounting treatment of warrants from the business combination, also lingered as an overhang. The structural mismatch between a micro-cap valuation, limited trailing revenue, and the need for repeated capital raises has kept sentiment cautious, even as management highlighted improving gross margins and progress on its product roadmap.
Looking ahead, investors will likely focus on the December 2026 shareholder vote related to the standby equity purchase agreement, since its outcome will shape the company's dilution and funding path. The commercial launch timelines for Kyro and NovaArm, along with progress on the Vietnam manufacturing facility, are key operational milestones that could influence sentiment.
Quarterly results and cash-burn trends will also be closely monitored given the company's limited cash reserves. Any additional financing, partnership, or customer-deployment announcements may move the stock materially, as will broader shifts in investor appetite for speculative AI and robotics names. As with any micro-cap in an early commercialization phase, outcomes remain uncertain and should be evaluated carefully. From what I see, tracking these catalysts with tools like Tickeron’s AI Trend Prediction Engine helps clarify the picture.
In my own research process, I’ve found Tickeron’s AI Trading Bots particularly useful for monitoring stocks like AMCI across different strategies and timeframes. The platform offers hundreds of bots that track thousands of tickers, and I often review the curated Trending AI Robots section to identify approaches gaining traction without sifting through everything manually. Each bot has its own risk profile and holding period, so checking performance details remains essential before applying any automated strategy. This kind of data-driven support fits well alongside traditional analysis when evaluating volatile names in emerging sectors.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
AMCI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 9 of 17 cases where AMCI's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 53%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AMCI's RSI Oscillator exited the oversold zone, 3 of 6 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 50%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 16 of 57 cases where AMCI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 28%.
The Moving Average Convergence Divergence (MACD) for AMCI just turned positive on October 28, 2026. Looking at past instances where AMCI's MACD turned positive, the stock continued to rise in 15 of 57 cases over the following month. The odds of a continued upward trend are 26%.
Following a +19.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMCI advanced for three days, in 47 of 108 cases, the price rose further within the following month. The odds of a continued upward trend are 44%.
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMCI as a result. In 19 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 23%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMCI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
The Aroon Indicator for AMCI entered a downward trend on October 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.725) is normal, around the industry mean (-7.717). P/E Ratio (-2.275) is within average values for comparable stocks, (-2.817). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (23.994). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (14.493) is also within normal values, averaging (51.774).
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. AMCI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMCI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ComputerProcessingHardware